Reports that the U.S.-based biopharmaceutical company, Amgen Inc. has won the patent lawsuit against pharmaceutical companies, Transkaryotic Therapies Inc. and Aventis Pharmaceuticals Inc. over its multi-billion dollar red blood cell-stimulating drug. Description of patent law for drugs; Details on the lawsuit.